The role of eNOS gene polymorphisms on contrast induced nephropathy development in chronic kidney disease patients

被引:0
|
作者
Kilic, Ilhan [1 ]
Palabiyik, Orkide [2 ]
Kurultak, Ilhan [3 ]
Sipahi, Tammam [2 ]
Ustundag, Sedat [3 ]
机构
[1] Edirne Sultan 1 Murat State Hosp, Nephrol Dept, Fatih St, TR-22030 Edirne, Turkey
[2] Trakya Univ, Biophys Dept, Edirne, Turkey
[3] Trakya Univ, Nephrol Dept, Edirne, Turkey
关键词
chronic kidney disease; contrast nephropathy; gene polymorphism; NITRIC-OXIDE PRODUCTION; PATHOGENESIS; ASSOCIATION; PROTEINS;
D O I
10.1111/1744-9987.13921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Contrast nephropathy is a result of contrast media given through intravascular routes. Nitric oxide gene polymorphisms may alter the hemodynamic stability resulting in medullary ischemia Nitric oxide gene polymorphisms may have an enhancing role in contrast media related renal injury. The aim of this study was to investigate the role of eNOS intron 4a/b, T786C, and G894T gene polymorphisms on contrast-nephropathy risk. Methods Ninety-four chronic kidney disease patients with contrast nephropathy and 120 chronic kidney disease patients without contrast nephropathy were included. DNA isolation was performed and specific regions of DNA for eNOS G894T, T786C, and intron 4a/b genes were amplified by polymerase chain reaction technique. Results TT polymorphism of T786C gene and GG polymorphism of G894T gene were detected to be possibly protective from contrast induced nephropathy. Conclusion Endothelial nitric oxide synthase G894T gene polymorphisms, older age, and presence of diabetes mellitus may influence contrast nephropathy development.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 50 条
  • [1] Evidence for the causative role of oxidative stress in the development of contrast-induced nephropathy in patients with chronic kidney disease
    Yamamoto, Eisei
    Takano, Hitoshi
    Kawashima, Shuji
    Kawanaka, Hidekazu
    Takahashi, Yasuhiro
    Takagi, Gen
    Fujita, Nobuhiko
    Aoki, Satoshi
    Asai, Kuniya
    Yasutake, Masahiro
    Takayama, Morimasa
    Mizuno, Kyoichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A368 - A368
  • [2] Is contrast medium dose a risk factor for the development of contrast-induced nephropathy in patients with chronic kidney disease?
    Kim, Byoung-Keuk
    Oh, Sungjin
    Choi, Daesik
    Kim, Kyung Heui
    Jeon, Deng Woon
    Yang, Joe Young
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 16B - 16B
  • [3] Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease
    Kroneberger, Christian
    Enzweiler, Christian N.
    Schmidt-Lucke, Andre
    Rueckert, Ralph-Ingo
    Teichgraeber, Ulf
    Franiel, Tobias
    ACTA RADIOLOGICA OPEN, 2015, 4 (06)
  • [4] Economical benefit of the prevention of contrast-induced nephropathy in patients with chronic kidney disease
    Takano, H.
    Yamamoto, E.
    Takano, M.
    Takagi, G.
    Asai, K.
    Yasutake, M.
    Mizuno, K.
    EUROPEAN HEART JOURNAL, 2009, 30 : 238 - 238
  • [5] Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease
    Toprak, O
    Cirit, M
    Esi, E
    Postaci, N
    Yesil, M
    Bayata, S
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 67 (02) : 227 - 235
  • [6] Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease
    Toprak, Omer
    Cirit, Mustafa
    Yesil, Murat
    Bayata, Serdar
    Tanrisev, Mehmet
    Varol, Umut
    Ersoy, Rifki
    Esi, Ertap
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (03) : 819 - 826
  • [7] Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease
    Jordan L. Rosenstock
    Emmanuelle Gilles
    Ari B. Geller
    Georgia Panagopoulos
    Staicy Mathew
    Deepa Malieckal
    Maria V. DeVita
    Michael F. Michelis
    International Urology and Nephrology, 2010, 42 : 1049 - 1054
  • [8] Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease
    Rosenstock, Jordan L.
    Gilles, Emmanuelle
    Geller, Ari B.
    Panagopoulos, Georgia
    Mathew, Staicy
    Malieckal, Deepa
    DeVita, Maria V.
    Michelis, Michael F.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (04) : 1049 - 1054
  • [9] Predictors of Contrast Induced Nephropathy in Patients with Chronic Kidney Disease after Percutaneous Coronary Intervention
    Kim, Hwan
    Choi, Seung-Hyuk
    Choi, Jin-Ho
    Gwon, Hyeon-Cheol
    Hahn, Joo-Yong
    Hong, Kyung Pyo
    Lee, Sang Hoon
    Park, Jeong Euy
    Bin Song, Young
    Yang, Jeong Hoon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B111 - B111
  • [10] Ace gene polymorphisms are ineffective on contrast induced nephropathy
    Kilic, Ilhan
    Palabiyik, Orkide
    Taylan, Gokay
    Sipahi, Tammam
    Ustundag, Sedat
    META GENE, 2022, 31